LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Acuitas Therapeutics Inc — Human Necessities
Acuitas Therapeutics Inc holds 80 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Acuitas Therapeutics Inc |
| Technology | Human Necessities |
| Patents in slice | 80 |
| Recent patents in slice | 34 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Acuitas Therapeutics Inc to Human Necessities.
LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
Recent filings
Latest patents from Acuitas Therapeutics Inc in Human Necessities.
LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
LIPID NANOPARTICLE mRNA VACCINES
US-2026090989-A1 · Apr 2, 2026 · US
Related pages
Navigate to parent entity pages.